Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients
While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients that initially respond well end up becoming unresponsive. Scientists have been working to develop tools that can help in predicting which patients are likely to benefit from immunotherapy, and a new liquid biopsy has provided a simpler way to do just that for patients with advanced lung cancer. According to a study that was published in the journal Clinical Cancer Research, a team at the Kimmel Cancer Research Center at Johns Hopkins together with their collaborators was able to develop a liquid biopsy that can accurately predict which patients will benefit from immunotherapy against…
